National and Kapodistrian University of Athens
Η συμμετοχή του Platelet Activating Factor (PAF) στην παθογένεια των όγκων του νεφρικού παρεγχύματος
Abstract
dc:descriptionThis study was designed to compare the expression of PAF and PAF-R in neoplastic and autologous normal kidney tissue and PAF levels in serum in human. Renal cell cancer (RCC) is extremely vascular tumor. Platelet-activating factor (PAF) is a glycerinetheric phoshpolipid pro-inflammatory mediator chemically characterized as 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholin. This unique molecule mediates its activities through a specific receptor (PAF-R). Among various pathophysiological conditions such as inflammation and atherosclerosis, PAF seems to be implicated also in cancer.There are numerous references indicating abnormalities in the expression of PAF and his receptor in various forms of human cancer, such as breast cancer, ovarian carcinoma, melanoma and colon cancer. The observation that renal tumors are extremely vascular and contain large amounts of glycogen, phospholipids and triglycerides suggests the involvement PAF in renal carcinoma.Serum samples were obtained on day before operation. Tissue specimens were obtained at the time of surgery from 98 patients undergoing nephrectomy for previously untreated RCC. Normal and adjacent tumor samples were immediately stored in vials containing ethyl alcohol. Histological evaluation was carried out following the UICC – AJCC, Fuhrman and TNM-2002 classification. PAF and PAF-R expression was assessed by immunohistochemistry and was correlated with patients’ important clinicopathological parameters, such as stage, grade and histological subtype.Differences in expression of PAF between RCC and oncocytomas was not significant in malignant renal tissue, but was more prominent in autologous normal kidney tissue in these cases. On the contrary PAF overexpression in normal and malignant renal tissue between RCC and benign tumors was statistically significant. Total expression of PAF in normal and malignant renal tissue was independent of tumour grade and disease stage, while it was more prominent in neoplastic tissue according to its grade. The value of PAF in serum was statistically significant in RCC in comparison with the benign tumors, but the mean value of PAF in serum (total, bound, unbound) was independent of tumour grade, disease stage and histological subtype.Overexpression of PAF-R in malignant tissue was independent of histological subtype, but was more prominent as disease stage and tumor grade increased.The PAF overexpression we observed in the majority of the tumor specimens supports a potential functional role for PAF and its receptor in controlling malignant transformation and cell growth in RCC. The exact functional role and the point of PAF involvement cannot be determined with clarity as the concentration in serum, the expression in malignant and autologous normal kidney tissue and the overexpression of PAF-R in malignant tissue cannot be absolutely correlated with clinical and pathological variables of the disease.Although other biological factors and receptors are also essential in the development and maintenance of cancerous growth, inhibition of PAF activation could be of value in treating certain RCC cases.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2010
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Mygdalis, Vasilios
- Μυγδάλης, Βασίλειος
Subjects
dc:subject × 16- Παράγοντας ενεργοποίησης αιμοπεταλίων
- Παθογένεια
- Αγγειογένεση
- Καρκινογένεση
- Νεφροκυτταρικός καρκίνος
- Platelet activating factor (PAF)
- Pathogenesis
- Angiogenesis
- Carcinogenesis
- Renal cell cancer
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29941